Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
September 9, 2021
Tags:
Chris McClain of Be The Match BioTherapies® discusses how the company is leveraging its extensive experience and well-established infrastructure to help speed novel cell therapies into the clinic and the market.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
